The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Excessive Expression of Acetylcholinesterase Impairs Glutamatergic Synaptogenesis in Hippocampal Neurons
Open accessAbstract
Acetylcholinesterase (AChE) exerts noncatalytic activities on neural cell differentiation, adhesion, and neuritogenesis independently of its catalytic function. The noncatalytic functions of AChE have been attributed to its peripheral anionic site (PAS)-mediated protein-protein interactions. Structurally, AChE is highly homologous to the extracellular domain of neuroligin, a postsynaptic transmembrane molecule that interacts with presynaptic β-neurexins, thus facilitating synaptic formation and maturation. Potential effects of AChE expression on synaptic transmission, however, remain unknown. Using electrophysiology, immunocytochemistry, and molecular biological approaches, this study investigated the role of AChE in the regulation of synaptic formation and functions. We found that AChE was highly expressed in cultured embryonic hippocampal neurons at early culture days, particularly in dendritic compartments including the growth cone. Subsequently, the expression level of AChE declined, whereas synaptic activity and synaptic proteins progressively increased. Chronic blockade of the PAS of AChE with specific inhibitors selectively impaired glutamatergic functions and excitatory synaptic structures independently of cholinergic activation, while inducing AChE overexpression. Moreover, the PAS blockade-induced glutamatergic impairments were associated with a depressed expression of β-neurexins and an accumulation of other synaptic proteins, including neuroligins, and were mostly preventable by antisense suppression of AChE expression. Our findings demonstrate that interference with the nonenzymatic features of AChE alters AChE expression, which impairs excitatory synaptic structure and functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AChE overexpression disrupts the glutaminergic system, resulting in damage to synaptic structures and excitatory structures.
“Additionally, studies suggest that AChE overexpression disrupts the glutaminergic system, resulting in damage to synaptic structures and excitatory structures [107].”
From Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits (2023) · cites this paper as [107]
Citations
Cites
Nijholt, I., Farchi, N., Kye, M., Sklan, E. H., Shoham, S., Verbeure, B., Owen, D., Hochner, B., Spiess, J., Soreq, H., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001446 · Cited by 126 · cited 2×
“Excess AChE emerges under conditions of stress (Meshorer et al., 2002; Nijholt et al., 2004) and exposure to AChE inhibitors (Kaufer et al., 1998).”
Self-citation
Flagged first, then by citations
Research works printed but not linked: 70
- 10.1073/pnas.94.15.8173 · DOI
- 1994, J Neurosci, 14, 2476, 10.1523/JNEUROSCI.14-05-02476.1994 · DOI
- 10.1002/hipo.1108 · DOI
- 1994, J Biol Chem, 269, 6296, 10.1016/S0021-9258(17)37371-4 · DOI
- 10.1016/S0960-9822(95)00211-9 · DOI
- 1997, J Neurochem, 69, 2441, 10.1046/j.1471-4159.1997.69062441.x · DOI
- 10.1016/S0006-8993(00)02046-1 · DOI
- 10.1093/protein/11.6.415 · DOI
- 10.1016/0092-8674(95)90128-0 · DOI
- 10.1096/fj.02-0609com · DOI
- 10.1002/jnr.490420510 · DOI
- 10.1038/sj.mp.4000383 · DOI
- 2002, J Neurosci, 22, 5791, 10.1523/JNEUROSCI.22-14-05791.2002 · DOI
- 10.1074/jbc.271.8.4410 · DOI
- 10.1046/j.1471-4159.2003.02230.x · DOI
- 10.1016/S0306-4522(02)00031-3 · DOI
- 10.1002/jnr.10436 · DOI
- 10.1038/nn1074 · DOI · Paper page
- 10.1002/(SICI)1098-1063(1999)9:3<314::AID-HIPO10>3.0.CO;2-7 · DOI
- 10.1016/0306-4522(95)00611-7 · DOI
- 10.1002/jnr.490390508 · DOI
- 10.1016/0006-2952(61)90145-9 · DOI
- 10.1089/neu.1998.15.349 · DOI
- 1989, Brain Res Dev Brain Res, 48, 73, 10.1016/0165-3806(89)90094-1 · DOI
- 10.1002/cne.902390210 · DOI
- 10.1089/108729001750072128 · DOI
- 1993, Brain Res Dev Brain Res, 76, 23, 10.1016/0165-3806(93)90119-U · DOI
- 1995, Exp Neurol, 134, 157, 10.1006/exnr.1995.1046 · DOI
- 10.1073/pnas.95.23.13935 · DOI
- 10.1016/0092-8674(95)90396-8 · DOI
- 10.1016/S0896-6273(00)80108-7 · DOI
- 10.1016/S0736-5748(00)00049-6 · DOI
- 10.1038/30741 · DOI · Paper page
- 1997, J Neurochem, 69, 1389, 10.1046/j.1471-4159.1997.69041389.x · DOI
- 10.1126/science.7569905 · DOI
- 10.1002/bies.950120904 · DOI
- 10.1007/BF00712798 · DOI
- 10.1007/BF00312823 · DOI
- 10.1016/S0896-6273(01)00194-5 · DOI
- 10.1159/000065054 · DOI
- 10.1016/S0928-4257(98)80007-7 · DOI
- 10.1126/science.1066752 · DOI
- 10.1074/jbc.M402752200 · DOI
- 10.1007/BF00334445 · DOI
- 1999, NeuroReport, 10, 3621, 10.1097/00001756-199911260-00029 · DOI
- 10.1021/bi00194a023 · DOI
- 2003, Mol Cell Neurosci, 23, 96, 10.1016/S1044-7431(03)00021-6 · DOI
- 2002, Neurol Sci, 23, S95, 10.1007/s100720200086 · DOI
- 10.1016/S0896-6273(01)00584-0 · DOI
- 10.1074/jbc.272.37.23265 · DOI
- 10.1002/ana.410200407 · DOI
- 10.1016/S0197-4580(02)00230-0 · DOI
- 10.1021/bi030150x · DOI
- 10.1016/j.neurobiolaging.2003.08.002 · DOI · Paper page
- 10.1016/S0092-8674(00)80877-6 · DOI · Paper page
- 10.1016/0165-3806(93)90061-E · DOI
- 10.1073/pnas.172511199 · DOI · Paper page
- 10.1016/j.tins.2003.09.004 · DOI
- 10.1126/science.1074069 · DOI · Paper page
- 1994, EMBO J, 13, 3448, 10.1002/j.1460-2075.1994.tb06650.x · DOI
- 10.1002/1097-4547(20010115)63:2<165::AID-JNR1008>3.0.CO;2-O · DOI
- 1999, Eur J Pharmacol, 377, 29, 10.1016/S0014-2999(99)00414-8 · DOI
- 10.1016/S1044-7431(03)00037-X · DOI
- 10.1007/s001090000104 · DOI
- 10.1073/pnas.96.3.1100 · DOI · Paper page
- 10.1038/35067589 · DOI
- 10.1016/S0092-8674(00)80921-6 · DOI
- 10.1007/BF00307630 · DOI
- 10.1038/nn883 · DOI · Paper page
- 10.1002/1098-1063(2000)10:5<512::AID-HIPO2>3.0.CO;2-M · DOI
Cited by
Sorted by citations
Wells, A. C., & Lotfipour, S. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11628 · Cited by 50
Zugno, A. I., Fraga, D. B., De Luca, R. D., Ghedim, F. V., Deroza, P. F., Cipriano, A. L., Oliveira, M. B., Heylmann, A. S. A., Budni, J., Souza, R. P., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.001 · Cited by 23
Metadata
- Authors
- Dong, H., Xiang, Y.-Y., Farchi, N., Ju, W., Wu, Y., Chen, L., Wang, Y., Hochner, B., Yang, B., Soreq, H., & Lu, W.-Y.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Hebrew University of Jerusalem (IL)
- University of Toronto (CA)
- Corresponding author
- Lu, Wei-Yang
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-10-13
- Volume
- 24
- Issue
- 41
- Pages
- 8950-8960
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6730061
- OpenAlex
- W2145669366
- Cited by
- 56
- References
- 1
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 6 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 4 · 2012: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- acetylcholinesterase, peripheral anionic site, excitatory synapses, hippocampal neurons, neuroligins, synaptic proteins, growth cones, synaptic transmission, AChE inhibitors
- MeSH terms
- Acetylcholinesterase, Animals, Binding Sites, Cells, Cultured, Cholinesterase Inhibitors, Enzyme Inhibitors, Hippocampus, Ligands, Nerve Tissue Proteins, Neurons, Synapses, Time Factors, Rats, Sprague-Dawley, In Situ Hybridization, Receptors, Glutamate, Patch-Clamp Techniques, Glutamic Acid, Growth Cones, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review